Detalhe da pesquisa
1.
Sequence not salvage.
Br J Haematol
; 204(5): 1590-1592, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563345
2.
Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment.
Haematologica
; 109(3): 777-786, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731379
3.
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1D): e240001, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244272
4.
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN.
Am J Hematol
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622840
5.
Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes.
Hum Mol Genet
; 30(12): 1142-1153, 2021 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751038
6.
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
Cancer
; 129(23): 3746-3760, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37622738
7.
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
Br J Haematol
; 200(5): 587-594, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495317
8.
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma: U.S. Myeloma Immunotherapy Consortium real world experience.
Haematologica
; 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855036
9.
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(1): 67-81, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652935
10.
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(12): 1281-1301, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081133
11.
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.
Eur J Haematol
; 111(3): 491-498, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382045
12.
Impact of academic medical center access on outcomes in multiple myeloma.
Am J Hematol
; 98(1): 41-48, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266759
13.
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma.
Future Oncol
; 19(1): 7-17, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779512
14.
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
Br J Haematol
; 199(3): 355-365, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111391
15.
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Blood
; 136(8): 936-945, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325490
16.
Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple Myeloma.
J Natl Compr Canc Netw
; 20(1): 91-95, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991076
17.
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
J Natl Compr Canc Netw
; 20(1): 8-19, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991075
18.
Palliative care utilization, transfusion burden, and end-of-life care for patients with multiple myeloma.
Eur J Haematol
; 109(5): 559-565, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054450
19.
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
Cancer
; 127(22): 4198-4212, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314018
20.
Hospitalization at the end of life in patients with multiple myeloma.
BMC Cancer
; 21(1): 339, 2021 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789626